It seems like you are referring to Tecvayli (teclistamab-cqyv). Here is some detailed information about Tecvayli based on the knowledge base:

Overview
- Tecvayli is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory multiple myeloma in adults
- It is intended for Show Full Answer

It seems like you are referring to Tecvayli (teclistamab-cqyv). Here is some detailed information about Tecvayli based on the knowledge base:

Overview
- Tecvayli is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory multiple myeloma in adults.
- It is intended for patients who have already tried at least four lines of therapy, including:
- A proteasome inhibitor
- An immunomodulatory agent
- An anti-CD38 monoclonal antibody

Mechanism of Action
- Tecvayli is a bispecific T-cell engager.
- The drug consists of a genetically engineered protein, or antibody, that targets:
- The B-cell maturation antigen (BCMA) on B cells, including myeloma cells
- The CD3 protein on T cells
- It works by prompting T cells to kill myeloma cells.

Administration
- Tecvayli is administered as a subcutaneous (under the skin) injection once a week after loading doses (initial large doses).
- It comes in the form of a single-dose vial.

Side Effects
- Common side effects include:
- Cytokine release syndrome (CRS), which can cause severe neurological symptoms such as hallucinations and tremors
- Fever
- Injection site reactions
- Fatigue
- Upper respiratory tract infections
- Nausea
- Headache
- Pneumonia
- Diarrhea
- Pain in the muscles, bones, or joints
- Rare but serious side effects include:
- Liver damage
- Severe or life-threatening infections
- Hypersensitivity reactions
- Fetal harm

For more details about this treatment, you can visit the official Tecvayli website provided by Janssen Biotech Inc.

 This AI-generated response comes from MyMyelomaTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Tecvayli (Teclistamab-cqyv) for Myeloma | MyMyelomaTeam

What Is BCMA-Targeted Immunotherapy for Multiple Myeloma? | MyMyelomaTeam